Vestal Point Capital, LP

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1974915 NEW YORK, NY

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$44,473,500

New position

Shares Held

75,000

first reported quarter

Ownership

0.177%

of shares outstanding

% of Portfolio

1.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $276,026,500 across 3 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (16.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	1,250,000	$164,675,000
2	BCRX	Biocryst Pharmaceuticals Inc	7,025,000	$66,878,000
3	UTHR	UNITED THERAPEUTICS Corp This page	75,000	$44,473,500

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$44,473,500	75,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.